Pfizer Profit Margin 2010-2023 | PFE

Current and historical gross margin, operating margin and net profit margin for Pfizer (PFE) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Pfizer net profit margin as of September 30, 2023 is 15.3%.
Pfizer Annual Profit Margins
Pfizer Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $169.279B $100.330B
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $567.306B 100.95
Novo Nordisk (NVO) Denmark $464.863B 42.98
Johnson & Johnson (JNJ) United States $360.875B 14.29
Merck (MRK) United States $260.194B 33.23
AbbVie (ABBV) United States $244.191B 11.60
Novartis AG (NVS) Switzerland $201.892B 14.03
AstraZeneca (AZN) United Kingdom $197.738B 17.72
Sanofi (SNY) $117.623B 10.64
Innoviva (INVA) United States $0.873B 7.87